Nestle S.A./ CH0038863350 /
12/11/2024 21:59:07 | Var. -0.9500 | Volume | Denaro- | Lettera- | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
88.6500USD | -1.06% | 809,392 Fatturato: 71.43 mill. |
-Quantità in denaro: - | -Quantità in lettera: - | 235.57 bill.USD | - | - |
GlobeNewswire
13/08
Seres Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
06/08
Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health Science
GlobeNewswire
23/07
Mondelēz International Names Filippo Catalano Chief Information and Digital Officer
GlobeNewswire
12/06
NFWF Announces $10.2 Million in Grants to Cultivate Conservation Practices on Agricultural Lands
GlobeNewswire
06/06
Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Sc...
GlobeNewswire
08/05
WalkMe Announces Date of First Quarter 2024 Financial Results and Conference Call
GlobeNewswire
26/03
NESTLE INTERNATIONAL AWARDED OMNIQ A PURCHASE ORDER FOR THE SUPPLY OF RUGGEDIZED IOT EQUIPMENT TO NE...
GlobeNewswire
19/03
VML Augments Digital Commerce Capabilities by Forging Partnership with CommerceIQ’s Unified Artifici...